
Free Daily Podcast Summary
by John Garrett
Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more.Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language.No bro science. No hype. Just clear, foundational education.For informational purposes only. Not medical advice.For Research Peptides; Offlinepeptides.com/ref/johngarrett/https://www.skool.com/peptides-explained-15
The most recent episodes — sign up to get AI-powered summaries of each one.
True-Sciences.com use code Pep20 for 20% off your first order What if some of the most important discoveries in regenerative medicine come not from replacing damaged cells, but from understanding how cells communicate? On this episode of Peptides Explained, John Garrett goes beyond the buzzwords surrounding stem cells and exosomes to explore the secretome—the complex collection of biological signals released by cells. We unpack growth factors, cytokines, extracellular vesicles, microRNAs, and the ways these signals may influence inflammation, tissue repair, remodeling, and cellular behavior. John explains why the cell is the factory and the secretome is its output—and why studying the output is not the same as proving that a manufactured preparation improves patient outcomes. You'll learn how extracellular vesicles differ from exosomes; why a molecule being present doesn't prove it reaches its target or creates a benefit; how cell sources and culture conditions affect what gets released; and what early human research does and does not show. John also shares a personal perspective: peptide medicines are an essential part of modern healthcare, but secretome science may be on the cusp of changing the way we think about healing and cellular communication. That's an informed prediction about the field's possibilities, not a claim that experimental secretome treatments are proven. This episode builds on John's earlier conversation with Sanjiv Lal, founder of Cell Factor and co-founder of Regen Therapy. This episode focuses on the biology and the evidence rather than reviewing a commercial product. Key topics: Cellular signaling; stem and stromal cells; paracrine effects; extracellular vesicles; exosomes; microRNA; inflammation; tissue repair; human clinical evidence; safety, manufacturing, and regulatory questions. Research links: https://doi.org/10.1002/jev2.12404 | https://pubmed.ncbi.nlm.nih.gov/39465400/ Peptides Explained App: https://app.peptidesexplained.info For educational purposes only. Experimental secretome-based interventions have not been established as safe or effective treatments for broad clinical uses. Speak with a qualified medical professional about treatment decisions. Any material financial relationships should be disclosed separately when applicable.
Weight loss is not the same thing as fat loss. A 2025 monkey study combining semaglutide with experimental myostatin and activin A antibodies raised the possibility of protecting lean mass while losing fat. Now COURAGE phase 2 data provide a human lean-mass preservation signal — alongside serious safety and tolerability concerns with the triple combination. John Garrett, RN, separates animal results, company-reported human data, body-composition measurements, and clinical outcomes. Trevogrumab and garetosmab are investigational monoclonal antibodies, not approved muscle-preserving peptides. Educational content only. Research links: https://doi.org/10.1038/s41467-025-59485-9 ; https://clinicaltrials.gov/study/NCT06299098 ; https://newsroom.regeneron.com/news-releases/news-release-details/phase-2-courage-trial-confirms-trevogrumab-prevents-lean-mass
True-Sciences.com use code Pep20 for 20% off your first order Dr. Hany Demian joins John Garrett for a conversation about chronic pain, injury recovery, regenerative medicine, and where peptides may fit in patient care. Drawing on his clinical experience, Dr. Demian discusses how he approaches patients with different needs, why he avoids a "kitchen sink" approach, and why sleep, nutrition, exercise, and careful assessment still matter. They also talk about clinical judgment, patient safety, and situations where peptides may not be appropriate. The conversation includes clinical anecdotes and personal perspectives. These do not establish that a peptide is safe or effective. Evidence for compounds such as BPC-157 and TB-500 remains limited. This episode is for educational purposes and is not individualized medical advice.
BPC-157 is back in the compounding-policy conversation—but what does HHS's new notice actually change, and what does the human evidence show? In this revisit, John Garrett looks at BPC-157's proposed biology, the three small published human reports, new clinical-trial registry entries, the FDA advisory committee's recommendation, and HHS's October 30 interim enforcement-discretion policy. The published human record remains small and very low certainty. For BPC-157, the HHS policy identifies the acetate form and specified dosage forms under limited Section 503A circumstances. It is conditional and interim; it does not make BPC-157 FDA-approved, add it to the 503A Bulks List, or establish that it works. We also explain why the anti-doping rules are a separate question. This episode is for informational purposes only and is not medical advice. Research and policy details were checked October 30, 2026; verify current status before publication.
What if the future of regenerative medicine isn't just about stem cells—but the biological messages those cells send? In this episode of Peptides Explained, John Garrett sits down with Sanjiv Lal, founder of Cell Factor and co-founder of Regen Therapy, to explore the emerging science of secretomes, cellular communication, and regenerative medicine. Sanjiv shares his personal journey from pharmaceutical sciences and molecular diagnostics to becoming a patient facing significant health challenges. That experience sparked his interest in cell-free regenerative technologies and the biological signaling systems involved in tissue repair, inflammation, and aging. Together, John and Sanjiv explore: Secretome science: What secretomes are and how they differ from stem cells and exosomes. Cellular communication: How peptides, growth factors, cytokines, and extracellular vesicles influence biological signaling. Cell Factor: Sanjiv's explanation of the technology, manufacturing process, and potential applications. Mitochondrial health: The relationship between cellular energy, inflammation, and biological function. Healthspan vs. lifespan: Why extending healthy, functional years matters as much as extending life. Peptides and longevity: Sanjiv's personal experience with Cell Factor, SS-31, MOTS-c, and other interventions. The future of healthcare: The potential role of preventive medicine, personalized diagnostics, and emerging regenerative technologies. Sanjiv also discusses his own health improvements and his vision for expanding access to regenerative medicine through Regen Therapy and related ventures. The bigger question: Can scientists harness cellular signaling to improve human health, and what clinical evidence will be needed to demonstrate that these approaches are safe and effective? This is a conversation about scientific possibility, innovation, and taking a more active role in long-term health. Learn more: Cell Factor: https://cell.health/ RegenTherapy https://regentherapy.com Important disclaimer: This episode is for educational purposes only and does not constitute medical advice. Cell Factor and the experimental approaches discussed should not be considered proven treatments for kidney disease, diabetes, aging, or other medical conditions. Personal experiences are not controlled clinical evidence. Consult a qualified healthcare professional before making treatment decisions.
True-Sciences.com Use Code Pep20 for 20% off. A careful look at CJC-1295: the growth-hormone pathway, the distinction between DAC and no-DAC naming, what small human studies measured, the terminated Phase 2 trial, current FDA compounding information, the unproven CJC-1295/ipamorelin combination claims, and WADA's 2026 rules. The evidence supports a hormone effect for the long-acting DAC-modified compound; it does not establish the benefits often marketed for consumer products. Educational content only; not medical advice. Snapshot checked October 19, 2026.
Seed oils may be hiding in more of your everyday foods than you realize. In this episode of Peptides Explained, host John talks with Cherie Calbom, MS—known as the Juice Lady—about seed oils, cooking fats, inflammation, and how to make more informed choices at the grocery store and when dining out.Cherie discusses how common seed oils are processed, why she recommends checking ingredient labels, and which alternatives she uses, including olive oil, avocado oil, coconut oil, ghee, and beef tallow. They also talk about omega-6 and omega-3 balance, cooking with different fats, and practical ways to make food swaps without giving up flavor.The conversation explores the history of seed oils and changing ideas about dietary fat and cholesterol. Cherie shares tips for spotting oils in packaged foods and describes resources for people who want to learn more, including her book The Truth About Seed Oils. Topics include: seed oils, cooking fats, inflammation, omega-6 and omega-3, food labels, nutrition, and healthy cooking.
Eli Lilly is taking legal action against businesses selling products labeled retatrutide. What do the lawsuits actually establish—and what don't they? John Garrett separates pending legal allegations from court findings, reviews the human trial evidence for the investigational triple agonist, and explains why molecular identity, purity, and pharmaceutical equivalence are not interchangeable. We also examine FDA restrictions, consumer safety, and the implications for clinics, vendors, and independent educators. Educational only; not medical or legal advice. Retatrutide is not FDA-approved. Sources: NEJM DOI 10.1056/NEJMoa2301972; FDA unapproved GLP-1 drug concerns; ClinicalTrials.gov NCT05929066 and NCT05882045.
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

The Hunter Williams Podcast
Explores cutting-edge science in peptides, hormone optimization, and biohacking with experts pushing the limits of human performance.

The Holistic GLP-1 Podcast with Elizabeth McGann
Explores holistic approaches to GLP-1 for metabolic health, weight, and well-being through expert insights and natural strategies.

Made for Health | Peptides | Lyme | Chronic Infections | Long Covid | Insulin Resistance | Hypermobility
A physician explores science-based approaches to treating chronic conditions and restoring health.

LONGEVITY with Nathalie Niddam
Explores science-backed strategies for extending healthspan through nutrition, biohacking, peptides, and emerging longevity research.

Get Better Faster
Doctors and researchers discuss functional medicine and root-cause approaches to chronic illness and health optimization.

Renee Belz & Lauren Sambataro
Biohacker Babes

Health vs Hype with the American Medical Association
A medical expert debunks viral health trends and misinformation with science-backed insights from physicians.

Sam Miller Science
Sam Miller

Peak Performance Life Podcast
Covers health, energy, and mental performance optimization through biohacking, nutrition, and lifestyle strategies.

Mind Pump: Raw Fitness Truth
Three fitness experts debunk myths and expose science-backed truths about training, nutrition, and health in the fitness industry.

FoundMyFitness
A podcast exploring health, science, nutrition, aging, and fitness.

The FastFit Podcast
FastFit
Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more.Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language.No bro science. No hype. Just clear, foundational education.For informational purposes only. Not medical advice.For Research Peptides; Offlinepeptides.com/ref/johngarrett/https://www.skool.com/peptides-explained-15
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Peptides Explained in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Peptides Explained as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by John Garrett.
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Peptides Explained covers topics including Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.